Scope and Limitations of The Co-Drug Approach to Topical Drug Delivery

E-ISSN： 1873-4286|14|8|794-802

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.8, 2008-03, pp. : 794-802

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical Delivery of a Naproxen-Dithranol Co-drug: In Vitro Skin Penetration, Permeation, and Staining

By Lau Wing White Alex Heard Charles

Pharmaceutical Research, Vol. 27, Iss. 12, 2010-12 ,pp. : 2734-2742

Springer Publishing Company

Access to resources Recommend Favorite

The scope and potential of vaginal drug delivery

By Vermani K. Garg S.

Pharmaceutical Science & Technology Today, Vol. 3, Iss. 10, 2000-10 ,pp. : 359-364

Elsevier

Access to resources Recommend Favorite

Ocular Drug Metabolism of the Bioactivating Antioxidant N-acetylcarnosine for Vision in Ophthalmic Prodrug and Codrug Design and Delivery

By Babizhayev Mark

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 10, 2008-10 ,pp. : 1071-1089

Informa Healthcare

Access to resources Recommend Favorite

Polymethacrylate Microparticles Gel for Topical Drug Delivery

By Labouta Hagar El-Khordagui Labiba

Pharmaceutical Research, Vol. 27, Iss. 10, 2010-10 ,pp. : 2106-2118

Springer Publishing Company

Access to resources Recommend Favorite

Pluronic lecithin organogel as a topical drug delivery system

By Pandey Mohit Belgamwar Veena Gattani Surendra Surana Sanjay Tekade Avinash

Drug Delivery, Vol. 17, Iss. 1, 2010-01 ,pp. : 38-47

Informa Healthcare

Access to resources Recommend Favorite